Amphion Innovations PLC Additional Draws on Loan Facility (1156R)
September 09 2014 - 2:00AM
UK Regulatory
TIDMAMP
RNS Number : 1156R
Amphion Innovations PLC
09 September 2014
Amphion Innovations plc
Additional Draws on Loan Facility
London and New York, 9 September 2014 - Amphion Innovations plc
(LSE: AMP) ("Amphion" or the "Company"), the developer of medical
and technology businesses, today announces that the Company has
agreed terms for the draw-down of an additional four consecutive
monthly tranches of $250,000 each (aggregating to $1 million) (each
an "Additional Draw") under the loan facility announced on 5 June
2014 ("Facility"). The first Additional Draw was made on 5
September 2014.
The Additional Draws are on substantially the same terms as the
Facility subject to the Lender receiving, on each Additional Draw,
78,035 simulated warrants in Kromek Group plc with an exercise
price of 61.25 pence per share and 1,274,583 warrants in Amphion
with an exercise price of 3.750 pence per share on the terms
previously announced. The Lender has agreed to a reduced
implementation fee on each Additional Draw of 6%.
The Additional Draws are to be used for working capital for
Amphion and its Partner Companies.
For further information please contact
Amphion Innovations plc
Charlie Morgan,
+1 (212) 210 6224
Novella Communications
Tim Robertson / Ben Heath
+44 020 3151 7008
Panmure Gordon Limited
Freddy Crossley / Duncan Monteith (Corporate Finance)
Charles Leigh-Pemberton (Corporate Broking)
+44 020 7886 2500
Plumtree Capital Limited (Advisor to Amphion)
Stephen Austin
+44 207 183 2493
+1 646 568 7502
About Amphion Innovations plc
Amphion (LSE: AMP) builds shareholder value in emerging
companies in the medical and technology sectors, by using a
focused, hands-on company building approach, based on decades of
experience in both the US and UK. Amphion has significant
shareholding in 7 Partner Companies developing proven technologies
targeting substantial commercial marketplaces. The Amphion model
has been refined to optimise the commercialisation of patents and
other intellectual property within the Partner Companies. The
Partner Companies collectively own or control over 200 separately
identified pieces of intellectual property, a number which grows
rapidly each year.
On the web: www.amphionplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCQKFDQQBKDDCK
Amphion Innovations (LSE:AMP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amphion Innovations (LSE:AMP)
Historical Stock Chart
From Apr 2023 to Apr 2024
